AAO News Archive
- Deal struck to develop integrin antagonist treatment
- New low-add multifocal IOLs yield higher patient satisfaction
- Regeneron, Bayer to develop AMD combination therapy
- FDA approves wide-field imaging system for newborns
- Brain mapping may someday lead to vision-restoring therapies
- FDA warns of loose safety seals on eye drops
- Stem cells regrow human lens, corneal tissue
Find an Eye MD near you!
- Details
The U.S. FDA has cleared the Pentacam AXL, which integrates anterior segment tomography and axial length measurement to allow for accurate IOL calculation.
Read more: New Pentacam device includes axial length measurement
- Details
Using a non-invasive contact lens sensor (CLS), the authors of this randomized trial assessed the effect of ocular hypotensive medications on a patient’s circadian IOP pattern.
Read more: Glaucoma medications don’t affect circadian IOP patterns
- Details
Scientists from the University College of London are studying the physics of the perfect pancake to improve surgical methods for treating glaucoma.
- Details
Researchers in Brazil are reporting vision-threatening retinal lesions in babies born with microcephaly that appear to be linked to infection with the mosquito-borne Zika virus.
Read more: Zika virus linked to retinal lesions in microcephalic infants
- Details
As DMEK surgery slowly becomes more popular as a treatment for endothelial dysfunction, it is important to assess if it is possible to safely reduce the use of corticosteroids after surgery.
Read more: Loteprednol prevents graft rejection with less IOP risk
- Details
The European Commission has approved Iridex’s Cyclo G6 laser system to perform cyclodestructive procedures in multiple stages of glaucoma.